7169-06-4

Basic information

• Product Name: 2,3-DIMETHOXY-BENZOYL CHLORIDE
• Synonyms: 2,3-DIMETHOXY-BENZOYL CHLORIDE
• CAS NO: 7169-06-4
• Molecular Formula: C₉H₉ClO₃
• Molecular Weight: 200.62
• Mol File: 7169-06-4.mol

Chemical Properties

• Boiling Point: 163°C/10mm
• Appearance: /
• CAS DataBase Reference: 2,3-DIMETHOXY-BENZOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIMETHOXY-BENZOYL CHLORIDE(7169-06-4)
• EPA Substance Registry System: 2,3-DIMETHOXY-BENZOYL CHLORIDE(7169-06-4)

Safety Data

• Hazardous Substances Data: 7169-06-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,3-DIMETHOXY-BENZOYL CHLORIDE is used as a reagent for esterifications and acylations in the synthesis of pharmaceuticals. Its high reactivity allows for the formation of esters and amides, which are essential components of many drugs.
Used in Agrochemical Industry:
2,3-DIMETHOXY-BENZOYL CHLORIDE is used as an intermediate in the synthesis of agrochemicals. Its ability to form esters and amides contributes to the development of various agrochemical products, such as pesticides and herbicides.
Used in Perfumery and Flavoring Industry:
2,3-DIMETHOXY-BENZOYL CHLORIDE is used as a precursor in the preparation of perfumes and flavorings. Its reactivity enables the formation of aromatic esters, which are key components in creating various fragrances and flavors.
Safety Considerations:
2,3-DIMETHOXY-BENZOYL CHLORIDE is known to be a lachrymator, causing tearing and irritation to the eyes when inhaled. Therefore, it should be handled with care and appropriate protective equipment, such as gloves, goggles, and respirators, to minimize exposure and potential health risks.

Upstream product

• 79-37-8 oxalyl dichloride 
• 1521-38-6 2,3-dimethoxybenzoic acid 
• 86-51-1 2,3-dimethyoxybenzaldehyde 
• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 

Downstream Products

• 109729-03-5 2-(2,3-dimethoxy-phenyl)-oxazolo[4,5-b]quinoxaline 
• 63484-36-6 2-{4'-[2-(2,3-Dimethoxy-benzoylamino)-ethyl]-biphenyl-4-yloxy}-2-methyl-propionic acid 
• 1854-64-4 (2,3-dimethoxyphenyl)heptyl ketone 
• 56475-30-0 C₃₉H₅₁N₃O₉ 
• 100533-08-2 3-(2,3-Dimethoxy-phenyl)-pentanol-(3) 
• 69421-89-2 N-{3-[(4-Chloro-phenyl)-methyl-amino]-2-hydroxy-propyl}-2,3-dimethoxy-benzamide 
• 60576-84-3 2,3-Dimethoxy-benzoic acid 2-dimethylamino-2-phenyl-butyl ester 
• 56475-31-1 2.3-Dimethoxybenzoylazid 
• 155644-82-9 (2-hydroxy-3-methoxyphenyl)(3-methyl-2-thienyl)methanone 
• 52203-23-3 2,3-dimethoxy-N,N-bis-(methylethyl)benzamide 
• 370580-53-3 2,3-dimethoxyphenyl-(5-methoxy-1-phenylsulfonyl-1H-2-indolyl)-methanone 
• 724433-55-0 N-diphenylphosphinoylmethyl-2,3-dimethoxy-N-methylbenzamide 
• 750649-55-9 N-(diphenyl-phosphinoylmethyl)-2,3-dimethoxy-N-(4-methoxy-benzyl)-benzamide 

Relevant articles and documents

Self-assembly of an amphiphilic iron(III) chelator: Mimicking iron acquisition in marine bacteria

(Figure Presented) Iron rations: Amphiphilic catechol-based chelators and their iron complexes self-assemble in solution at physiological pH values to form spherical particles (see cryo-TEM image). In terms of iron nutrition properties these abiotic chela

The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors

The total synthesis of berberine and selected analogues. And their evaluation as amyloid β (Aβ) aggregation inhibitors is described. The key step in the synthesis, the assembly of the berberine framework, was accomplished using an intermolecular Heck reaction. Berberine analog 17 incorporating a tertiary amine moiety showed good anti Aβ aggregation activity, water solubility, and almost no toxicity to nerve cells.

Computational discovery, structural optimization and biological evaluation of novel inhibitors targeting transient receptor potential vanilloid type 3 (TRPV3)

Transient receptor potential vanilloid type 3 (TRPV3) is a Ca2+ permeable nonselective cation channel and expressed abundantly in skin keratinocytes. TRPV3 emerges as an attractive target for treatment of pruritic, inflammatory, pain and skin-related diseases. However, only a few reports of TRPV3 inhibitors exist at present besides some patents. Therefore, TRPV3 research has always been fraught with challenges. Through a combination of virtual screening and biological evaluation, compound P1 (10 μM) was identified as a top hit with 34.5% inhibitory effect on 2-APB (1 mM)-evoked currents of mTRPV3-WT. Further structural optimization provided the inhibitor PC5 with the best activity (IC50 = 2.63 ± 0.28 μM), and point mutation assays indicated that amino acids V629 and F633 are crucial for the binding of PC5 and TRPV3. In summary, these newly discovered inhibitors could serve as promising lead compounds for the development of TRPV3 inhibitors in the future.

Design, synthesis and apoptosis inducing activity of nonsteroidal flavone-methanesulfonate derivatives on MCF-7 cell line as potential sulfatase inhibitor

In recent years, focusing on new potent anticancer agents with selective activity is one of the greatest challenges in cancer therapy. Breast cancer is the most common cancer and the main cause of cancer deaths in women. The sulfatase enzyme plays an important role in converting the sulfated steroids into non-sulfate steroid hormones, which increases the growth and development of many hormone-dependent cancers, such as breast cancer. In this regard, structure-based optimization was conducted to design novel flavone-sulfonates pharmacophore as a new steroid sulfatase inhibitor. In the present work, the conventional methods for the synthesis of 4-oxo-2-phenyl-4H-chromen-7-yl methanesulfonate derivatives were reported. Their cytotoxicity was evaluated with MTT assay against a breast cancer cell line (MCF-7). The apoptosis inducing activity of the most cytotoxic compound 3c with an IC50 value of 0.615 μM was evaluated in comparison to docetaxel in the presence of estradiol which is a crucial growth factor to survive the cancerous cells. The results of double staining Annexin V-FITC/PI analysis suggested that the cytotoxic activity of this compound 3c in MCF-7 cells occurs via apoptosis. Molecular docking studies were conducted to clarify the inhibition mode of the most promising compound (3c) over the sulfatase (1P49) binding site. The analysis revealed the role of hydrogen bond interaction with Gly181 and hydrophobic interactions through the 1P49 active site in the ligand-receptor complex as significant descriptors to rationalize the potential inhibition activity. [Figure not available: see fulltext.]

TYK2 Inhibitor compounds containing alkoxy and amide groups

The invention belongs to the field of pharmaceutical chemistry, and provides TYK2 inhibitor compounds containing alkoxy and amide groups and a preparation method thereof, and relates to application of the compound in preparation of medicines for treating

IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF

Compounds may have at least two structural units, which may be referred to as ligands. Each structural unit includes at least one spacer group and two or more donor groups. Compounds may have two or more iron(III) cations, one or more of which may be a hi

Synthesis, characterization, antioxidant, and antibacterial activities of new 2,3-dimethoxy and 3-acetoxy-2-methyl benzamides

Abstract: We performed a series of novel benzamide compounds which were synthesized starting from 2,3-dimethoxybenzoic acid or 3-acetoxy-2-methylbenzoic acid and amine derivatives. All the obtained products were purified, and the analysis of these product

Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors

Steroid sulfatase (STS) is a sulfatase enzyme that catalyzes the conversion of sulfated steroid precursors to free steroid. The inhibition of STS could abate estrogenic steroids that stimulate the proliferation and development of breast cancer, and therefore STS is a potential target for adjuvant endocrine therapy. In this study, a series of 3-benzylaminocoumarin-7-O-sulfamate derivatives targeting STS were designed and synthesized. Structure-relationship activities (SAR) analysis revealed that attachment of a benzylamino group at the 3-position of coumarin improved inhibitory activity. Compound 3j was found to have the highest inhibition activity against human placenta isolated STS (IC50 0.13 μM) and MCF-7 cell lines (IC50 1.35 μM). Kinetic studies found compound 3j to be an irreversible inhibitor of STS, with KI and kinact value of 86.9 nM and 158.7 min?1, respectively.

6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers

Aiming to deepen the structure–activity relationships of the two P-glycoprotein (P-gp) modulators elacridar and tariquidar, a new series of amide and ester derivatives carrying a 6,7-dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline scaffold linked to different methoxy-substituted aryl moieties were synthesised. The obtained compounds were evaluated for their P-gp interaction profile and selectivity towards the two other ABC transporters, multidrug-resistance-associated protein-1 and breast cancer resistance protein, showing to be very active and selective versus P-gp. Two amide derivatives, displaying the best P-gp activity, were tested in co-administration with the antineoplastic drug doxorubicin in different cancer cell lines, showing a significant sensitising activity towards doxorubicin. The investigation on the chemical stability of the derivatives towards spontaneous or enzymatic hydrolysis, showed that amides are stable in both models while some ester compounds were hydrolysed in human plasma. This study allowed us to identify two chemosensitizers that behave as non-transported substrates and are characterised by different selectivity profiles.

A two-qubit molecular architecture for electron-mediated nuclear quantum simulation

A switchable interaction between pairs of highly coherent qubits is a crucial ingredient for the physical realization of quantum information processing. One promising route to enable quantum logic operations involves the use of nuclear spins as protected